Advertisement

Cefuroxime Sodium Injection

[02 November 2016]

Products Affected - Description

Zinacef powder for solution for injection, Teligent
1.5 gram, vial, 10 count (NDC 24987-0354-10)
 
Cefuroxime powder for solution for injection, Sagent
1.5 gram, vial, 25 count (NDC 25021-0119-20)
7.5 gram, bulk vial, 10 count (NDC 25021-0120-59)
750 mg, vial, 25 count (NDC 25021-0118-10)
 
Cefuroxime powder for solution for injection, West-Ward
1.5 gram, vial, 25 count (NDC 00143-9977-22)

Reason for the Shortage

  • Teligent has Zinacef on shortage due to increased demand.
  • West-Ward did not provide a reason for the cefuroxime injection shortage.

Available Products

Zinacef injection, Teligent
1.5 gram/50 mL, premixed bag, 24 count, NDC 24987-0425-00
Zinacef powder for solution for injection, Teligent
1.5 gram, ADD-Vantage vial, 10 count, NDC 24987-0437-00
7.5 gram, bulk vial, 6 count, NDC 24987-0400-00
750 mg, ADD-Vantage vial, 25 count, NDC 24987-0436-00
750 mg, vial, 10 count, NDC 24987-0352-10
 
Cefuroxime powder for solution for injection, West-Ward
7.5 gram, bulk vial, 10 count, NDC 00143-9976-03
750 mg, vial, 25 count, NDC 00143-9979-22

Estimated Resupply Dates

  • West-Ward has cefuroxime 1.5 gram vials on back order and the company cannot estimate a release date.
  • Sagent has cefuroxime 750 mg and 1.5 gram vials on back order and the company estimates a release date of November 2016. The 7.5 gram vials are on back order and the company cannot estimate a release date.
  • Teligent has Zinacef 1.5 gram vials on back order and the company estimates a release date of 1st quarter 2017.

Related Shortages

Updated

November 2, May 17 and 2, 2016; November 5, September 23, August 12, July 2 and 1, May 22 and 8, April 7 and 6, February 26, January 14, 2015; December 8, October 13, August 26, 13 and 4, July 9, June 25, April 11, March 14, January 15, 2014; December 10, August 27 and 1, July 16, June 6, April 12, March 22 and 8, February 6, January 29 and 25, 2013, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing